Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Clindamycin (as clindamycin hydrochloride)
Chanelle Animal Health Ltd.
QJ01FF01
Clindamycin (as clindamycin hydrochloride)
75 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs
clindamycin
Antibacterial
Authorised
1999-01-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clinacin 75 mg Tablets for Dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Clindamycin 75 mg (as clindamycin hydrochloride) EXCIPIENT: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. A round white tablet, with a break-line on one side. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of:- Infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of: · Staphylococcus spp. · Streptococcus spp. · Bacteroides spp. · Fusobacterium necrophorum · Clostridium perfringens Osteomyelitis: · Staphylococcus aureus 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to clindamycin or lincomycin. Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of clindamycin by these species may result in severe gastro-intestinal disturbance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _8_ _/_ _1_ _1_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _4_ _9_ _3_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should Preberite celoten dokument